Therefore, our data indicated that the upregulation of GSTA2 provides protective advantages for HCCs against high ROS-induced damage during the early phase after LT and subsequently increases the likelihood of HCC recurrence. This evidence concerns the gene GSTA2 and hepatocellular carcinoma.